Myeloperoxidase antibody (FITC)

Catalog No. ABIN2191799

The Mouse Monoclonal anti-Myeloperoxidase antibody has been validated for IA. It is suitable to detect Myeloperoxidase in samples from Mouse. There are 4+ publications available.

Quick Overview for Myeloperoxidase antibody (FITC) (ABIN2191799)

Target: Myeloperoxidase (MPO)

Reactivity: Mouse

Host: Mouse

Clonality: Monoclonal

Conjugate: This Myeloperoxidase antibody is conjugated to FITC

Application: Immunoassay (IA)

Clone: 8F4

Product Details anti-Myeloperoxidase Antibody (FITC)

Cross-Reactivity (Details): Cross reactivity: Rat MPO : Yes

Sterility: 0.2 μm filtered

Isotype: IgG1

Application Details

Application Notes: For immunohistochemistry and flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50 Positive Neutrophils isolated from digested infarcts control 1

Restrictions: For Research Use only

Handling

Buffer: PBS, containing 1 % bovine serum albumin and 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.

References for anti-Myeloperoxidase antibody (FITC) (ABIN2191799)

Matthijsen, Huugen, Hoebers, de Vries, Peutz-Kootstra, Aratani, Daha, Tervaert, Buurman, Heeringa: "Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion." in: The American journal of pathology, Vol. 171, Issue 6, pp. 1743-52, (2007) (PubMed).

van Leeuwen, Gijbels, Duijvestijn, Smook, van de Gaar, Heeringa, de Winther, Tervaert: "Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 1, pp. 84-9, (2007) (PubMed).

Wang, DCosta, Civin, Friedman: "C/EBPalpha directs monocytic commitment of primary myeloid progenitors." in: Blood, Vol. 108, Issue 4, pp. 1223-9, (2006) (PubMed).

Huugen, Xiao, van Esch, Falk, Peutz-Kootstra, Buurman, Tervaert, Jennette, Heeringa: "Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha." in: The American journal of pathology, Vol. 167, Issue 1, pp. 47-58, (2005) (PubMed).

Target Details for Myeloperoxidase

Target: Myeloperoxidase (MPO)

Alternative Name: Myeloperoxidase

Background: The monoclonal antibody 8F4 recognizes mouse myeloperoxidase (MPO). MPO is a glycoprotein produced as a single precursor, which is subsequently cleaved into a alpha and beta chain. In human the biologically active MPO is a 150 kDa tetramer composed of 2 glycosylated alfa chains of 59-64 kDa and 2 beta chains of 14 kDa. MPO is stored in azurophilic granules of polymorphonuclear leukocytes and is rapidly released into the phagosome and extracellular space during inflammatory conditions.The enzyme catalyzes the conversion of chloride and hydrogen peroxide to hypochlorite, a potent oxidant, which functions in host defense against microorganisms. Involvement of MPO has been described in several human diseases, such as cardiovascular disease, airway inflammation, lung cancer, Alzheimer's disease and multiple sclerosis. A positive correlation between elevated MPO levels in serum and cardiovascular disease suggest an interesting role for MPO as an diagnostic marker, making it possible to identify patients at risk for future cardiac events. Furthermore, there are some autoimmune diseases, in which MPO is targeted by antineutrophil cytoplasm antibodies. Studies with MPO-knockout mice have shown an increased susceptibility to pneumonia following intratracheal infections. Moreover, MPO deficient mice are more susceptible to experimental autoimmune encephalitis, a T cell-dependent neuronal disease, and have an increased expression of arteriosclerotic plaques compared to wild-type mice. The anti-mouse MPO monoclonal antibody 8F4 recognizes natural MPO in biological solutions by ELISA, in frozen tissue sections fixed with acetone and in flow cytometry using a cell permeabilization method. The antibody 8F4 is cross-reactive with rat MPO. Immunogen Purified mouse MPO from WEHI-3 cells

Pathways: Chromatin Binding